Market revenue in 2023 | USD 141.1 million |
Market revenue in 2030 | USD 250.4 million |
Growth rate | 8.5% (CAGR from 2023 to 2030) |
Largest segment | Small molecule |
Fastest growing segment | Large Molecule |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Small Molecule, Large Molecule |
Key market players worldwide | Thermo Fisher Scientific Inc, Icon PLC, Charles River Laboratories International Inc, Labcorp Holdings Inc, IQVIA Holdings Inc, Syneos Health, SGS AG, Intertek Group PLC, Pace Analytical Services |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to bioanalytical testing services market will help companies and investors design strategic landscapes.
Small molecule was the largest segment with a revenue share of 53.93% in 2023. Horizon Databook has segmented the Netherlands bioanalytical testing services market based on small molecule, large molecule covering the revenue growth of each sub-segment from 2018 to 2030.
Several medical device CROs operate within the country. The increasing consolidation in the outsourcing sector is linked to CROs expanding their global presence. ICON's bioanalytical laboratories, which support various sponsor companies, actively collaborate closely with academic institutions such as the University of Groningen in the Netherlands.
This collaborative approach ensures that ICON remains at the forefront of industry needs, staying ahead of the curve in delivering comprehensive solutions.
The consolidation between academic institutions and key industry players in the bioanalytical testing services market creates a collaborative ecosystem that fosters innovation, accelerates technological advancements, and enhances the overall efficiency of the drug development process.
Horizon Databook provides a detailed overview of country-level data and insights on the Netherlands bioanalytical testing services market , including forecasts for subscribers. This country databook contains high-level insights into Netherlands bioanalytical testing services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account